An exploratory behavioral intervention trial to improve rates of screening for AIDS clinical trials among racial/ethnic minority and female persons living with HIV/AIDS

AIDS and Behavior

Volumn 14, Issue 3, 2010, Pages 639-648

  Gwadz, Marya Viorst ^a   Cylar, Keith ^b   Leonard, Noelle R ^a   Riedel, Marion ^c   Herzog, Nina ^d   Arredondo, Gricel N ^a   Cleland, Charles M ^a   Aguirre, Michael ^e   Marshak, Ann ^e   Mildvan, Donna ^e  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b Housing Works Inc   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Independent Consultant   (United States)

^e BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Behavioral intervention; Gender disparities; HIV AIDS clinical trials; Motivational interviewing; Racial ethnic disparities; Screening

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CLINICAL TRIAL (TOPIC); ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH CARE DISPARITY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; INTERVIEW; MALE; MINORITY GROUP; MINORITY HEALTH; MOTIVATION; PATIENT SELECTION; SEX DIFFERENCE; WOMEN'S HEALTH;

AFRICAN AMERICANS; CLINICAL TRIALS AS TOPIC; ETHNIC GROUPS; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; INTERVIEWS AS TOPIC; MALE; MINORITY GROUPS; MINORITY HEALTH; MOTIVATION; PATIENT SELECTION; SEX FACTORS; WOMEN'S HEALTH;

EID: 77956875508     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-009-9539-9     Document Type: Article

References (39)

1. Allison P. D. (1999). Logistic regression using the SAS system: Theory and application. Cary, NC: SAS Institute.
2. Anderson, D. (2004). A guide to patient recruitment and retention. Boston, MA: Thomson CenterWatch.
3. Bach, P. B., Cramer, L. D., Warren, J. L., & Begg, C. B. (1999). Racial differences in the treatment of early-stage lung cancer. The New England Journal of Medicine, 341(16), 1198-1205. doi:10.1056/NEJM199910143411606. (Pubitemid 29480659)
4. Bandura, A. (1986). Social foundations of thought and action. Englewood Cliffs, NJ: Prentice Hall.
5. Cargill, V. A., & Stone, V. E. (2005). HIV/AIDS: A minority health issue. The Medical Clinics of North America, 89(4), 895-912. doi:10.1016/j.mcna.2005.03.005. (Pubitemid 40755549)
6. Centers for Disease Control and Prevention. (2005). Viral hepatitis, STD and TB prevention HIV/AIDS among African-American. Retrieved June 15, 2007, from http://www.cdc.gov/hiv/topics/aa/resources/factsheets/aa.htm.
7. Centers for Disease Control and Prevention. (2006a). HIV/AIDS among Hispanics. Retrieved April 15, 2008, from http://www. cdc.gov/hiv/hispanics/ resources/factsheets/hispanic.htm
8. Centers for Disease Control and Prevention. (2006b). Racial/ethnic disparities in diagnoses of HIV/AIDS-33 states, 2001-2004. MMWR, 55(5), 121-125.
9. Cole, S. R., & Ananth, C. V. (2001). Regression models for unconstrained, partially or fully constrained continuation odds ratios. International Journal of Epidemiology, 30(6), 1379-1382. doi:10.1093/ije/30.6. 1379.
10. Ding, E. L., Powe, N. R., Manson, J. E., Sherber, N. S., & Braunstein, J. B. (2007). Sex differences in perceived risks, distrust, and willingness to participate in clinical trials. A randomized study of cardiovascular prevention trials. Archives of Internal Medicine, 167(9), 905-912. doi:10.1001/archinte.167.9.905. (Pubitemid 46762752)
11. Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R. H., Watters, J., Andersen, M., et al. (1994). Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383-392.
12. El-Sadr, W., & Capps, L. (1992). The challenge of minority recruitment in clinical trials for AIDS. Journal of the American Medical Association, 267(7), 954-957. doi:10.1001/jama.267. 7.954.
13. Gandhi, M., Ameli, N., Bacchetti, P., Sharp, G. B., French, A. L., Young, M., et al. (2005). Eligibility criteria for HIV clinical trials and generalizability of results: The gap between published reports and study protocols. AIDS (London, England), 19(16), 1885-1896. doi:10.1097/01.aids. 0000189866.67182.f7.
14. Gifford, A. L., Cunningham, W. E., Heslin, K. C., Andersen, R. M., Nakazono, T., Lieu, D. K., et al. (2002). Participation in research and access to experimental treatments by HIV-infected patients. The New England Journal of Medicine, 346(18), 1373-1382. doi:10.1056/NEJMsa011565. (Pubitemid 34754611)
15. Gwadz, M. V., Leonard, N. R., Nakagawa, A., Cylar, K., Finkelstein, M., Herzog, N., et al. (2006). Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgrounds. AIDS Care, 18(7), 786-794. doi:10.1080/09540120500428952. (Pubitemid 44395525)
16. Hankins, C., Lapointe, N., & Walmsley., S. (1998). Participation in clinical trials among women living with HIV in Canada. Canadian Medical Association, 159(11), 1359-1365.
17. Harrell, F. E., Margolis, P. A., Gove, S., Mason, K. E., Mulholland, E. K., Lehmann, D., et al. (1998). Development of a clinical prediction model for an ordinal outcome: The World Health Organization multicentre study of clinical signs and etiological agents of pneumonia, sepsis and meningitis in young infants. WHO/ARI Young Infant Multicentre Study Group. Statistics in Medicine, 17(8), 909-944. doi:10.1002/(SICI)1097-0258(19980 430)17:8B909:AID-SIM753C3.0. CO;2-O.
18. Harris Interactive. (2000). Cancer clinical trials: Opportunities for increasing enrollment (study no. 11799). Harris Interactive, Inc.: New York.
19. Killien, M., Bigby, J. A., Champion, V., Fernandez-Repollet, E., Jackson, R. D., Kagawa-Singer M., et al. (2000). Involving minority and underrepresented women in clinical trials: The National Centers of Excellence in Women's Health. Journal of Women's Health & Gender-Based Medicine, 9(10), 1061-1070.
20. King, T. E., Jr. (2002). Participation in research and access to experimental treatments by HIV-infected patients. The New England Journal of Medicine, 346(18), 1400-1402. doi:10.1056/ NEJM200205023461812.
21. King, W. D., Defreitas, D., Smith, K., Andersen, J., Perry, L. P., Adeyemi, T., et al. (2007). Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: A descriptive study. AIDS Patient Care and STDs, 21(8), 551-563. doi:10.1089/apc.2006.0173. (Pubitemid 350194957)
22. Lynn, L. A. (1997). AIDS clinical trials: Is there access for all? Journal of General Internal Medicine, 12(3), 198-199.
23. Marshak, A., Costantini, G., Middleton, S., Barnett, S., Garmon, D., Gwadz, M., Leonard, N., Nakagawa, A., Mildvan, D., & Project ACT Collaborative Research Team. (2007). Screening for AIDS clinical trials in the project ACT cohort of racial/ethnic minorities and women in New York City: Substantial interest but low eligibility. Abstract published in CD-ROM. IAS conference on hiv pathogenesis, treatment and prevention, Sydney, Australia.
24. Merigan, T. C. (1990). You can teach an old dog new tricks: How AIDS trials are pioneering new strategies. The New England Journal of Medicine, 323(19), 1341-1343.
25. Miller, W., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York: Guilford.
26. Moore, R. D., Bone, L. R., Geller, G., Mamon, J. A., Stokes, E. J., & Levine, D. M. (1989). Prevalence, detection, and treatment of alcoholism in hospitalized patients. Journal of the American Medical Association, 261(3), 403-407. doi:10.1001/jama.261. 3.403. (Pubitemid 19032983)
27. National Institute of Allergy and Infectious Diseases. (2005). HIV infection in minority populations. Retrieved April 5, 2008, from http://www.niaid.nih.gov/factsheets/Minor.htm.
28. National Institute on Drug Abuse. (1991). Risk behavior assessment. Bethesda, MD: Community Research Branch, National Institute on Drug Abuse.
29. Nova Research Company. (2001). Questionnaire Development System (version 2) [computer software]. Bethesda, MD: Nova Research Company.
30. Parada, J. (2000). The changing face of AIDS. Minority Health Today, 1(5), 9-17
31. RAND Corporation. (1995). HIV cost and services utilization study (HCSUS) baseline questionnaire. Santa Monica, CA: RAND.
32. Sengupta, S., Strauss, R. P., DeVellis, R., Quinn, S. C., DeVellis, B., & Ware, W. B. (2000). Factors affecting African-American participation in AIDS research. Journal of Acquired Immune Deficiency Syndromes, 24(3), 275-284.
33. Shapiro, M., Morton, S., McCaffrey, D., Senterfitt, J., Fleishman, J., Perlman, J., et al. (1999). Variations in the care of HIV-infected adultsin the United States: Results from the HIV Cost and Services Utilization Study. Journal of the American Medical Association, 281(24), 2305-2315. doi:10.1001/jama.281. 24.2305. (Pubitemid 29289823)
34. Steele, C. B., Richmond-Reese, V., & Lomax, S. (2006). Racial and ethnic disparities in HIV/AIDS, sexually transmitted diseases, and tuberculosis among women. Journal of Women's Health, 15(2), 116-122. doi:10.1089/jwh.2006.15. 116.
35. Sullivan, P. S., McNaghten, A. D., Begley, E., Hutchinson, A., & Cargill, V. A. (2007). Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines. Journal of the National Medical Association, 99(3), 242-250.
36. UyBico, S. J., Pavel, S., & Gross, C. P. (2007). Recruiting vulnerable populations into research: A systematic review of recruitment interventions. Journal of General Internal Medicine, 22(6), 852-863. doi:10.1007/s11606-007-0126-3. (Pubitemid 46763959)
37. Wendler, D., Kington, R., Madans, J., Van Wye, G., Christ-Schmidt, H., et al. (2006). Are racial and ethnic minorities less willing to participate in health research? PLoS Medicine, 3(2), 0201-0210.
38. Wu, A., Hays, R., Kelly, S., Malitz, F., & Bozzette, S. A. (1997). Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Quality of Life Research, 6(6), 531-554. doi:10.1023/A:1018460132567. (Pubitemid 27431708)
39. Wynia, M. K., & Gamble, V. N. (2006). Mistrust among minorities and the trustworthiness of medicine. PLoS Medicine, 3(5), 0701-0702.